Related Experiment Video
Updated: Aug 16, 2026
10:17
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
[Pharmacosurveillance III: international experience]
Leticia Rodríguez Betancourt1, José Luis García Vigil, Carmen Giral Barnés
1Centro de Información de Medicamentos, Universidad Autonoma del Estado de Morelos (IMSS-UAEM), USA.
Revista Medica Del Instituto Mexicano Del Seguro Social
|August 11, 2005
Summary
This study examines global adverse drug reaction reports, identifying leading countries and therapeutic classes. It analyzes reporting trends adjusted for population size, offering insights into drug safety worldwide.
Area of Science:
- Pharmacovigilance and Drug Safety
- International Health and Epidemiology
- Clinical Pharmacology
Context:
- Adverse drug reactions (ADRs) represent a significant global health concern.
- Understanding international ADR reporting patterns is crucial for effective drug safety surveillance.
- Previous research has established the importance of pharmacovigilance but lacks comprehensive international comparative analysis.
Purpose:
- To analyze and compare international experiences with adverse drug reactions (ADRs).
- To identify countries with the highest cumulative ADR report numbers and assess population-adjusted reporting rates.
- To detail the frequency of ADRs across twenty therapeutic drug classes and their associated clinical manifestations.
Summary:
- This article presents an analysis of global ADR data, highlighting leading countries based on cumulative and population-adjusted report numbers.
- It ranks twenty therapeutic drug classes by ADR report frequency, providing explanations for observed patterns.
- The study also consolidates data on the cumulative reports for specific clinical manifestations of ADRs.
Impact:
- Provides a global perspective on drug safety and pharmacovigilance activities.
- Informs regulatory bodies and healthcare professionals about high-risk therapeutic areas and geographical trends in ADRs.
- Facilitates targeted interventions and resource allocation for improving international drug safety monitoring.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...